home / stock / xsnx / xsnx quote
Last: | $0.0065 |
---|---|
Change Percent: | 0.23% |
Open: | $0.006485 |
Close: | $0.0065 |
High: | $0.0065 |
Low: | $0.005 |
Volume: | 85,468 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0065 | $0.006485 | $0.0065 | $0.0065 | $0.005 | 85,468 | 05-03-2024 |
$0.0065 | $0.0065 | $0.0065 | $0.0065 | $0.0056 | 55,632 | 05-02-2024 |
$0.00699 | $0.007 | $0.00699 | $0.007 | $0.00601 | 70,465 | 05-01-2024 |
$0.007 | $0.007 | $0.007 | $0.007 | $0.007 | 39,957 | 04-30-2024 |
$0.0055 | $0.005 | $0.0055 | $0.0074 | $0.005 | 4,993,074 | 04-29-2024 |
$0.0051 | $0 | $0.0051 | $0 | $0 | 4 | 04-26-2024 |
$0.0051 | $0.0062 | $0.0051 | $0.0065 | $0.005 | 3,508,043 | 04-25-2024 |
$0.007 | $0.0075 | $0.007 | $0.008 | $0.0065 | 1,222,515 | 04-24-2024 |
$0.008 | $0.0065 | $0.008 | $0.0085 | $0.0065 | 1,070,506 | 04-23-2024 |
$0.007 | $0.0066 | $0.007 | $0.008545 | $0.0066 | 639,176 | 04-22-2024 |
$0.0077 | $0.007625 | $0.0077 | $0.0078 | $0.007555 | 256,500 | 04-19-2024 |
$0.008 | $0.0087 | $0.008 | $0.0087 | $0.0074 | 1,060,093 | 04-18-2024 |
$0.00905 | $0.0097 | $0.00905 | $0.0097 | $0.00904 | 121,128 | 04-17-2024 |
$0.0081 | $0.0095 | $0.0081 | $0.00965 | $0.0078 | 630,854 | 04-16-2024 |
$0.01 | $0.0099 | $0.01 | $0.01 | $0.00975 | 326,410 | 04-15-2024 |
$0.01025 | $0.01 | $0.01025 | $0.012 | $0.009 | 847,761 | 04-12-2024 |
$0.011 | $0.01 | $0.011 | $0.011 | $0.01 | 700,120 | 04-11-2024 |
$0.011 | $0.011 | $0.011 | $0.012 | $0.009327 | 633,312 | 04-10-2024 |
$0.0125 | $0.0135 | $0.0125 | $0.014 | $0.0125 | 215,747 | 04-09-2024 |
$0.0135 | $0.011 | $0.0135 | $0.0141 | $0.01 | 884,988 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
CLEVELAND, OH / ACCESSWIRE / April 30, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing a novel immunotherapy for patients suffering from cancers of the central nervous system, today announced the procurement of a new intellectual property license from Cedars-Sinai Medi...
CLEVELAND, OH / ACCESSWIRE / March 1, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today provided an update on business developments, financing and the 2024 annual meeting. The previously disclosed $10.7 million finan...
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...